Aboelnaga Engy M, Ahmed Rehab Allah
1 Clinical Oncology and Nuclear Medicine Department, 2 Pathology Department, Faculty of Medicine, Mansoura University, Mansoura 35511, Egypt.
Cancer Biol Med. 2015 Mar;12(1):53-9. doi: 10.7497/j.issn.2095-3941.2015.0005.
Differentiated thyroid carcinomas (DTCs) are classified into papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC). DTCs are analyzed as a single group in clinical studies that investigated the prognostic factors and prognosis of these malignancies. However, the biological behaviors of these carcinomas significantly differ. In the present study, we aimed to detect differences in the outcomes between PTC and FTC in Mansoura University Hospital in Egypt.
A total of 558 patients with histologically proven thyroid carcinomas from January 2003 to December 2012 were retrospectively enrolled. The clinical and pathological data of patients were reviewed.
Large primary tumor size, lymph node involvement, extrathyroid extension, and distant metastasis were significant poor prognostic factors for overall survival (OS) in old PTC patients. Cox hazard analysis showed that the patient's age, extra thyroid extension, and distant metastasis were the only independent prognostic factors. In FTC patients, only the distant metastasis and degree of tumor invasion were significant poor prognostic factors in OS univariate analysis. However, these factors were nonsignificant in multivariate analysis. The 10-year OS rates were 97% and 89% for PTC and FTC, respectively (P=0.003). The 10-year disease-free survival (DFS) rates were 77.2% in PTC vs. 65% in FTC (P=0.179).
The significant prognostic factors vary between the two types of DTCs. Therefore, PTC and FTC patients need to be analyzed and reported independently. PTC survival is widely and significantly affected by age, extrathyroid extension, and distant metastasis. By contrast, these factors were nonsignificant in FTC, which showed poorer survival than PTC.
分化型甲状腺癌(DTC)分为乳头状甲状腺癌(PTC)和滤泡状甲状腺癌(FTC)。在研究这些恶性肿瘤的预后因素和预后的临床研究中,DTC被作为一个单一的组进行分析。然而,这些癌的生物学行为有显著差异。在本研究中,我们旨在检测埃及曼苏拉大学医院PTC和FTC患者的预后差异。
回顾性纳入2003年1月至2012年12月期间558例经组织学证实的甲状腺癌患者。对患者的临床和病理数据进行了回顾。
在老年PTC患者中,原发肿瘤体积大、淋巴结受累、甲状腺外侵犯和远处转移是总生存期(OS)的显著不良预后因素。Cox风险分析显示,患者年龄、甲状腺外侵犯和远处转移是仅有的独立预后因素。在FTC患者中,单因素分析显示远处转移和肿瘤侵犯程度是OS的显著不良预后因素。然而,在多因素分析中这些因素并不显著。PTC和FTC的10年OS率分别为97%和89%(P=0.003)。PTC的10年无病生存率(DFS)为77.2%,FTC为65%(P=0.179)。
两种类型的DTC之间显著的预后因素有所不同。因此,PTC和FTC患者需要独立分析和报告。PTC的生存广泛且显著地受到年龄、甲状腺外侵犯和远处转移的影响。相比之下,这些因素在FTC中并不显著,FTC的生存率低于PTC。